Turing Pharmaceuticals is playing into the hands of Hillary's attack on drug prices, and may do serious damage to the pharma companies who actually are innovating. The people who developed the new $$$$ Hep C drug came up with a novel drug for a serious disease. Turing Pharmaceuticals is just gaming the regulatory system.
A little Googling reveals that Duraprim IS a generic — it’s just that this guy Martin Schkreli has the only current US rights. At this price, he’ll attract competitors, and surely knows that at best he’s getting a short-term windfall.
Bit of a dirtbag move, though.